Erasca Insider Purchases Yet To Pay Off Regardless Of Recent Strength
H.C. Wainwright Maintains Erasca(ERAS.US) With Buy Rating, Maintains Target Price $6
Erasca Price Target Maintained With a $6.00/Share by HC Wainwright & Co.
Erasca Analyst Ratings
Erasca Presents New RAS-targeting Franchise Data at AACR Meeting
Express News | Erasca Presents New Preclinical Data For Profiles Of RAS-Targeting Franchise At 2025 AACR Annual Meeting
Analysts Have Conflicting Sentiments on These Healthcare Companies: Pfizer (PFE), Vertex Pharmaceuticals (VRTX) and Erasca (ERAS)
Wolverine World Wide, Pacira BioSciences And Other Big Stocks Moving Higher On Monday
Is Erasca Inc. (NASDAQ:ERAS) the Best Biotech Penny Stock to Buy According to Hedge Funds?
Erasca Slides As Insider Purchases Lose Another US$84k
Morgan Stanley Maintains Erasca(ERAS.US) With Buy Rating, Maintains Target Price $4
Morgan Stanley Keeps Their Buy Rating on Erasca (ERAS)
Erasca (ERAS) Gets a Buy From J.P. Morgan
New Analyst Forecast: $ERAS Given $5.0 Price Target
Raymond James Initiates Erasca(ERAS.US) With Buy Rating, Announces Target Price $5
This Spotify Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday
Raymond James Initiates Erasca at Outperform With $5 Price Target
Analysts Are Bullish on Top Healthcare Stocks: Vera Therapeutics (VERA), Erasca (ERAS)
BofA Securities Maintains Erasca(ERAS.US) With Buy Rating, Maintains Target Price $5
H.C. Wainwright Initiates Erasca(ERAS.US) With Buy Rating, Announces Target Price $6